The next standard of care: Medical University of South Carolina's (MUSC) innovative genomics initiative

Gone are the days where genomics is singularly viewed as expensive, hard to implement, and lacking clear benefits and return on investment. 

For forward-thinking healthcare leaders, genomic screening is on the brink of becoming the standard of care.

In this whitepaper, you'll read three experts' thoughts on the evolving clinical and research landscape for genomics, as well as the business case for population genomics at an academic medical center.

Key learnings:
  • Explore MUSC's innovative genomics initiative
  • The growth of enterprise genomics programs
  • How population genomics is transforming clinical care and driving strategic growth

Please fill out the form to download the whitepaper.